Cathie Wood: 36 Intellia Therapeutics transactions (ARK Invest / NTLA)

36 Cathie Wood Intellia Therapeutics Trades

Cathie Wood acquired 14.5M Intellia Therapeutics shares worth $214M. That's 1.43% of their equity portfolio (24th largest holding). The investor owns 13.56% of the outstanding Intellia Therapeutics stock. The first Intellia Therapeutics trade was made in Q4 2016. Since then Cathie Wood bought shares 27 more times and sold shares on eight occasions. The investor's estimated purchase price is $445M, resulting in a loss of 52%.

Avg closing price

Price range

Increased shares by 2.1% (+302k shares) Q1 2026

Avg closing price $13.18

Price range $9.21 - $15.90

Increased shares by 19.2% (+2.29M shares) Q4 2025

Avg closing price $13.69

Price range $8.04 - $27.98

Sold 8.4% shares (-1.1M shares) Q3 2025

Avg closing price $12.28

Price range $9.88 - $17.76

Increased shares by 0.1% (+6.86k shares) Q2 2025

Avg closing price $8.24

Price range $6.28 - $9.67

Increased shares by 3.8% (+475k shares) Q1 2025

Avg closing price $10.13

Price range $7.11 - $12.80

Increased shares by 2.3% (+281k shares) Q4 2024

Avg closing price $15.50

Price range $11.41 - $21.08

Increased shares by 5.7% (+660k shares) Q3 2024

Avg closing price $23.05

Price range $19.72 - $27.36

Increased shares by 5.5% (+607k shares) Q2 2024

Avg closing price $23.81

Price range $20.02 - $27.22

Sold 3.7% shares (-423k shares) Q1 2024

Avg closing price $27.78

Price range $23.82 - $32.80

Increased shares by 14.7% (+1.46M shares) Q4 2023

Avg closing price $28.74

Price range $23.16 - $32.34

Increased shares by 4.4% (+423k shares) Q3 2023

Avg closing price $38.80

Price range $31.62 - $45.78

Sold 3.2% shares (-311k shares) Q2 2023

Avg closing price $40.55

Price range $34.58 - $46.03

Increased shares by 4.4% (+416k shares) Q1 2023

Avg closing price $39.22

Price range $33.30 - $44.82

Sold 2.4% shares (-236k shares) Q4 2022

Avg closing price $47.55

Price range $33.21 - $62.69

Increased shares by 1.5% (+142k shares) Q3 2022

Avg closing price $62.04

Price range $53.92 - $71.70

Increased shares by 5.9% (+534k shares) Q2 2022

Avg closing price $50.78

Price range $38.49 - $76.21

Increased shares by 13.4% (+1.06M shares) Q1 2022

Avg closing price $84.72

Price range $58.27 - $118.99

Increased shares by 17.4% (+1.17M shares) Q4 2021

Avg closing price $125.27

Price range $100.76 - $138.36

Sold 12.2% shares (-941k shares) Q3 2021

Avg closing price $151.40

Price range $132.37 - $176.78

Sold 20.1% shares (-1.93M shares) Q2 2021

Avg closing price $77.87

Price range $60.88 - $161.91

News about Intellia Therapeutics Inc and Cathie Wood

Cathie Wood''s ARK buys Intellia stock, sells Tesla and Verve

https://www.investing.com/news/company-news/cathie-woods-ark-buys-intellia-stock-sells-tesla-and-verve-93CH-3509465

Investing.com, almost 2 years ago

3 Stocks Cathie Wood Just Bought to Get Back on Track in the Second Half of 2024

Wood added to her positions in Palantir, Archer Aviation, and Intellia Therapeutics on Monday. Palantir is one of her largest holdings, and the big data anal...

fool.com, almost 2 years ago

Wall Street Favorites: 3 Cathie Wood Stocks With Strong Buy Ratings for June 2024

Investors looking for long-term returns should consider investing in strong buy Cathie Wood stocks this month. The ARK Invest Chief Executive Officer (CEO) g...

investorplace.com, almost 2 years ago